05.04.2014 Views

Gallbladder Stones - IAGH

Gallbladder Stones - IAGH

Gallbladder Stones - IAGH

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Gallstone Disease<br />

Farhad Zamani<br />

Associated professor of Gastroenterology and Hepatology<br />

IUMS<br />

GILDRC<br />

Zamani.farhad@gmail.com


Epidemiology<br />

• Gallstones (GS) have existed for more than<br />

35 centuries.<br />

– They have been documented in Egyptian<br />

mummies<br />

• 20 million Americans have GS<br />

• 700,000 cholecystectomys performed<br />

annually in the U.S.<br />

• Most common gastrointestinal disorder<br />

requiring hospitalization


Prevalence<br />

• GS disease increases with age in both sexes<br />

• GS are more common in women at every age<br />

» 22.4% of women aged 60-69<br />

» 11.5% of men aged 60-69<br />

• For each 10 year period after age 40 the<br />

incidence of new GS formation is 3%<br />

• Cholesterol GS common in developed countries<br />

• Pigmented GS common in developing countries


Ethnic Variation<br />

• Prevalence varies with ethnicity<br />

» Highest rates in North American Caucasians, Pima<br />

Indians, Swedish<br />

» Lowest rates in Asian and Sub-Saharan African<br />

• Suggests a role for both genetics and<br />

environmental influences in the<br />

pathogenesis of GS


Gallstone Pathogenesis<br />

Cholesterol and Pigmented GS<br />

Lithogenic<br />

Bile<br />

Nucleation<br />

Stasis<br />

GS<br />

Formation


Cholesterol GS<br />

• Mechansims of cholesterol GS formation<br />

– Hypersecretion of cholesterol into bile<br />

– Hyposecretion of bile acids into bile<br />

– Nucleation factors<br />

– <strong>Gallbladder</strong> mucin<br />

– Role of gallbladder


Cholesterol Solubilization<br />

• Free cholesterol is insoluble in bile, requires<br />

Bile acids and Phospholipids<br />

• Mixed micelles<br />

– Cholesterol, phospholipid and bile acids<br />

• Unilamellar vesicles<br />

– Cholesterol and phospholipid<br />

– Relatively unstable, cholesterol rich and<br />

nucleation prone<br />

– Predominantly formed during bile stasis<br />

– Generate Multi-lamellar vesicles


Mechanisms of GS Formation<br />

•Cholesterol Hyper-secretion<br />

•Bile acid Hypo-secretion


Cholesterol Hyper-secretion<br />

• Obesity<br />

– Increased hepatic<br />

synthesis<br />

– Increased dietary<br />

cholesterol<br />

• Hormones<br />

– Estrogens, OCP’s<br />

– Decreased conversion<br />

to cholesterol esters<br />

– Increased hepatic<br />

uptake<br />

• Genetic<br />

– Increased transport and<br />

uptake<br />

– ↓ 7- ά -hydroxylase<br />

activity (↓BA production)<br />

• Rapid Weight Loss<br />

– Mobilization of cholesterol<br />

stores<br />

• Advancing Age


Bile Acid Hypo-secretion<br />

• Ileal Disease<br />

– Loss of enterohepatic circulation of bile acids<br />

• Congenital<br />

– 12 hydroxylase deficiency, results in decreased<br />

production of BA<br />

• Cholestatic liver diseases<br />

– PBC<br />

– PSC


Lithogenic Bile<br />

• Patients may have problems with both<br />

Hyper-secretion and Hypo-secretion<br />

• The net effect of these disorders is to<br />

produce a bile that is supersaturated with<br />

cholesterol and poor in bile acids<br />

• These conditions favor cholesterol GS<br />

formation


Nucleation (promoters)<br />

• Nucleation is an early and indispensable<br />

step in GS formation<br />

• Promote vesicular fusion and solid<br />

cholesterol crystal formation<br />

• Biliary proteins bind pigment, cholesterol<br />

crystals and phospholipid


<strong>Gallbladder</strong> (GB)<br />

• Important in the pathogenesis<br />

• GB concentrates BA<br />

– Results in viscous bile<br />

– Promotes nucleation<br />

• Secretes mucin<br />

– Promoter<br />

• GB motility plays a vital role<br />

– Normally GB contraction expels sludge and stones<br />

– GB hypo-motility results in stasis of bile<br />

– Promotes sludge and stone formation<br />

• Cholecystectomy prevents recurrent cholelithiasis


• microlithiasis<br />

Biliary Sludge<br />

• microcrystals seen on histologic examination of<br />

a fresh bile specimen<br />

• calcium salts, cholesterol crystals and mucin gel<br />

• U/S<br />

– Low amplitude echo without post-acoustic<br />

shadowing (as seen in stones) that layers with gravity<br />

• May represent an early stage in stone formation<br />

– 18% resolve<br />

– 14% GS<br />

– 19% acalculous cholecystitis


Cholesterol Gallstone


Pigmented Gallstones<br />

• Classifed as Brown or Black pigmented<br />

• Similar underlying mechansims in cholesterol<br />

stone formation<br />

– Lithogenic Bile<br />

– Nucleation<br />

– Stasis<br />

• Predominantly bilirubin pigments and calcium<br />

salts, rather than cholesterol<br />

• Pathogenesis involves deconjugation and<br />

precipitation of bilirubin


Characteristics of Pigmented GS<br />

Characteristic Black GS Brown GS<br />

Size < 1cm > 1cm<br />

Location <strong>Gallbladder</strong> Bile ducts<br />

Association<br />

Hemolysis,<br />

Cirrhosis<br />

Cholangitis,<br />

Parasites<br />

Culture Sterile Bacteria, Ova<br />

Composition<br />

Bilirubin, Calcium<br />

salts<br />

Bilirubin, fatty<br />

acids, cholesterol


Black Pigmented <strong>Stones</strong>


Brown Pigmented <strong>Stones</strong>


Pigmented Gallstones


Risk factors<br />

Age<br />

Gender<br />

2.9 F/M at 30-39 y<br />

1.6 F/M at 40-49 y<br />

1.2 F/M at 50-59 y<br />

FH and genetics : 2-5 times<br />

Obesity : Increase cholesterol synthesis<br />

Serum lipid : Increase in ↑TG. and apolipoprotein,<br />

no associated to cholesterol level


Risk Factors<br />

Pregnancy :<br />

qualitative change of BA → increased chenodeoxyelolate<br />

60% sludge and 30% stone less than l cm resolves after delivery<br />

Sex Hormone :<br />

Progesterone → reduction in BA secretion, slowing GB emptying<br />

Estrogen → increase cholesterol secretion


Risk factors<br />

• Drugs: Clofibrate , ceftriaxone<br />

• Rapid weight loss :gastric by pass ,UDCA dec. risk<br />

• Diabetes mellitus : 2 times, mostly in women


Risk Factors<br />

• Cirrhosis :<br />

• Reduced hepatic synthesis and transport of BA<br />

• High estrogen level<br />

• Impaired GB contraction to meal<br />

• <strong>Gallbladder</strong> stasis :<br />

• Spinal cord injury<br />

• prolonged fasting<br />

• TPN<br />

• Somatostatin ( ↓ CCK)


Protective factors<br />

• Ascorbic acid :<br />

protective in women ?<br />

Cholesterol catabolism?<br />

• Coffee:<br />

moderate coffee consumption<br />

decreased 40% symptomatic gallstone


Chronic cholcystitis<br />

• A pathologist term to describe chronic<br />

inflammatory cell infiltration of the<br />

gallbladder seen on histopathology<br />

• Invariably associated with GS<br />

• May be result of mechanical irritation or<br />

recurrent attacks of acute cholecystitis


Chronic cholcystitis<br />

• Its presence does not correlate with symptoms<br />

• Extensive chronic inflammatory may have only<br />

minimal symptoms<br />

• No evidence that chronic cholecystitis<br />

increases the risk for future morbidity<br />

• Clinical significance is questionable

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!